Details for 2018724892

Up to date per 02.04.2026

Actions

Title / Product Name

CUMARINDERIVAT ZUR THERAPIE ODER PROPHYLAXE EINER STÖRUNG DER ZELLPROLIFERATION

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018724892

EP Publication Number

3709996

E-Number

1660589

Language

PCT Number

EP18062805

Publication Date

23.09.2020 A

28.02.2024 B1

Registration Date

28.02.2024

AT Publication Date

15.03.2024

Application Date

16.05.2018

Registration Number

Priorities

16.11.2017

PCT/EP2017/079506

IPC

A61K 31/37 20060101AFI20190524BHEP

Maximum Duration of Protection

16.05.2038

Owner

The Institute of Cancer Research: Royal Cancer Hospital123 Old Brompton Road London SW7 3RPGB

The Royal Marsden NHS Foundation TrustFulham Road London SW3 6JJGB

Representative

SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT

Inventor

BANERJI, Udaic/o The Institute of Cancer Research: Royal Cancer Hospital 123 Old Brompton Road London SW7 3RPGB

Information about Fees